Showing results (181-190 of 397) with videos related to

Sort By:
Pageof 40
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 12, 1998
Increased atherogenicity of low-density lipoprotein in heavy proteinuriaC J Deighan, M J Caslake, M McConnell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 4, 2000
Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formationC J Deighan, M J Caslake, M McConnell, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal diseaseChristopher J Deighan, Muriel J Caslake, Michael McConnell, et al.
The Journal of Experimental Zoology|September 1, 1985
Calcium mobilization, water balance, and growth in embryos of the agamid lizard Amphibolurus barbatusM J Packard, G C Packard, J D Miller, et al.
British Journal of Clinical Pharmacology|August 20, 2011
The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatinNicholas G Martin, Ka Wah Li, Heather Murray, et al.
Annals of Clinical Biochemistry|July 1, 1993
A pilot scheme for improving the accuracy of serum cholesterol measurement in Scotland and Northern IrelandC J Packard, M A Bell, R H Eaton, et al.
European Journal of Clinical Investigation|February 1, 1992
Plasma triglyceride and low density lipoprotein metabolismM J Caslake, C J Packard, J J Series, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 15, 1977
Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemiaF C Ballantyne, D K Bedford, D Ballantyne, et al.
Journal of the American College of Cardiology|September 25, 2024
Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL CholesterolElias Björnson, Martin Adiels, Anders Gummesson, et al.
Pageof 40